Therefore, based on our results, we hypothesize that the SNP rs4252707 may contribute to the risk of developing non-GBM glioma by somehow influencing the expression of MDM4, such as by affecting the splice sites or by being closely linked with some functional variations. Here, MDM4 is linked to central nervous system cancer.